CD177 and cancer: The MEK-ERK pathway (also known as the ERK pathway) is an evolutionarily highly conserved signaling cascade that can transmit signals from cell surface receptors to promote cell proliferation and survival.22–24 The components of the ERK signaling cascade are often mutated in cancer, and inhibitor molecules targeting related kinases in the ERK pathway are gradually being used in antitumor therapy.